Le Lézard
Classified in: Health

VENN Skincare Launches In One Of The Largest South Korean Retailers


LOS ANGELES, April 26, 2018 /PRNewswire/ -- VENN Skincare, Inc., a company setting a new standard for the skincare industry, is proud to announce that its Age-Reversing All-In-One Concentrate, a game-changing all-in-one that delivers multiple benefits for all skin types, has officially launched at SSG.COM, which is an e-commerce division of Shinsegae, South Korea's prestige retailer.

VENN Skincare, Inc. (PRNewsfoto/VENN Skincare, Inc.)

Shinsegae has added VENN's all-in-one concentrate to its online skincare offerings at SSG.COM, providing its customers with VENN's efficient, effective, and safe all-in-one that is clinically tested to fight the signs of aging skin, deliver hydration, and improve the appearance of fine lines, wrinkles, and discoloration. 

"As a skincare company with our R&D based in South Korea, we're thrilled to be added to the Shinsegae family," said Brian Oh, Founder and CEO of VENN Skincare. "We've seen great success in the South Korean market since our launch in November last year, and are honored to offer our multi-purpose skincare to this prestigious, respected retailer's customer base."

Based on over 20 years of research, and delivering visible results in a single step, VENN's all-in-one concentrate eliminates the needs for multiple products, including serums, ampoules, creams, and oils.

Hero Ingredients & Concentric TechnologyTM 

VENN's all-in-one concentrate contains Ginsenoside Compound K as a key ingredient, which scientific literature has indicated fights and eliminates free radicals and active oxygen in the skin, promotes collagen production, and improves skin elasticity and firmness. This skin saving hero ingredient reduces the signs of aging while working with powerful peptides and botanicals that are effectively delivered to skin through VENN's proprietary Concentric TechnologyTM (international patents pending).

Comprised of three technologies that reinforce each other to ensure ingredients are effectively dissolved and delivered, Concentric TechnologyTM is VENN's key to age-defying results.

To learn more about VENN Skincare and VENN Age-Reversing All-In-One Concentrate, please visit: https://vennskincare.com/.

VENN Age-Reversing All-In-One Concentrate retails for 275,000 KRW (250 USD) on SSG.COM.

About VENN Skincare, Inc.:
Brian Oh, a NYC and Silicon Valley lawyer with a deep passion for skincare, set out on a mission to find a safe and effective regimen that met his demanding lifestyle. An avid user of premium products, Brian found the beauty counter cluttered with bottles of serums, ampoules, creams, oils, and more, that all claimed different results, and multiple steps that he could not devote daily time to. Brian set out to change the industry and introduce a new category that would meet the needs of a modern lifestyle?anti-aging, all-in-one skincare that not only streamlines routines, but is just as, if not more, effective than other high-end products on the market.

Media contact: Emily Nugent; [email protected]

 

                                                          

SOURCE VENN Skincare, Inc.


These press releases may also interest you

at 09:18
Innovations in patient care developed at Florida Cancer Specialists & Research Institute, LLC (FCS) will be presented at the Oncology Nursing Society 49th Annual Congress in Washington, DC, the largest global gathering dedicated to oncology nursing....

at 09:18
FORUS Therapeutics Inc. ("FORUS") is deeply disappointed and disagrees with the recent decision by the Honourable Christian Dubé, Minister of Health and Social Services in Quebec to deny listing XPOVIO® (selinexor) in combination with VELCADE®...

at 09:18
The Inception Company, trusted provider of meeting solutions to the life sciences industry and HCPs (healthcare professionals) for over 20 years and known for its Pandotm platform, announces a pivotal role expansion for its in-house Executive...

at 09:15
n-Lorem, a nonprofit foundation, announced a new partnership with Hongene Biotech Corporation that supports n-Lorem's efforts to discover and provide personalized experimental antisense oligonucleotide (ASO) medicines to nano-rare disease patients (1...

at 09:15
Synaptogenix, Inc. ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, today announced that it received notice from The Nasdaq Stock Market LLC ("Nasdaq") on April 22,...

at 09:11
For over 30 years Protocall's behavioral health contact center, HelpNow, has set industry standards for round-the-clock access to high-quality crisis care. Received calls are documented within Protocall's custom database and sent to the caller's care...



News published on and distributed by: